Skip to main content

Secnidazole News

Lupin Announces FDA Approval of Supplemental New Drug Application for Solosec (secnidazole) for the Treatment of Trichomoniasis

BALTIMORE, July 1, 2021 /PRNewswire/ --Lupin Pharmaceuticals, Inc., the U.S. based wholly-owned subsidiary of global pharma major Lupin Limited (Lupin), announced today that the U.S. Food and Drug...

FDA Approves Symbiomix Therapeutics’ Solosec (secnidazole) Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women

NEWARK, N.J.--(BUSINESS WIRE) September 18, 2017 --Symbiomix Therapeutics today announced the U.S. Food and Drug Administration (FDA) has approved Solosec (secnidazole) 2g oral granules for the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Trichomoniasis, Bacterial Vaginitis

Secnidazole patient information at Drugs.com